Cargando…
Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy
Zinc therapy is normally utilized for treatment of Wilson disease (WD), an inherited condition that is characterized by increased levels of non-ceruloplasmin bound (‘free’) copper in serum and urine. A subset of patients with Alzheimer’s disease (AD) or its prodromal form, known as Mild Cognitive Im...
Autores principales: | Squitti, Rosanna, Pal, Amit, Picozza, Mario, Avan, Abofazl, Ventriglia, Mariacarla, Rongioletti, Mauro C., Hoogenraad, Tjaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466035/ https://www.ncbi.nlm.nih.gov/pubmed/32784855 http://dx.doi.org/10.3390/biom10081164 |
Ejemplares similares
-
Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
por: Pal, Amit, et al.
Publicado: (2022) -
Evaluation of zinc, copper, and Cu:Zn ratio in serum, and their implications in the course of COVID-19
por: Ivanova, Irena D., et al.
Publicado: (2022) -
Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
por: Pal, Amit, et al.
Publicado: (2021) -
Zinc and COVID-19: Basis of Current Clinical Trials
por: Pal, Amit, et al.
Publicado: (2020) -
Agricultural Use of Copper and Its Link to Alzheimer’s Disease
por: Coelho, Fábio C., et al.
Publicado: (2020)